These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 33072746)

  • 1. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
    Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
    Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenine RNA modification and cancer.
    Yang J; Chen J; Fei X; Wang X; Wang K
    Oncol Lett; 2020 Aug; 20(2):1504-1512. PubMed ID: 32724392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of m6A methyltransferase component VIRMA in multiple human cancers (Review).
    Zhu W; Wang JZ; Wei JF; Lu C
    Cancer Cell Int; 2021 Mar; 21(1):172. PubMed ID: 33731118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
    Liu WW; Wang H; Zhu XY
    Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate.
    Ji P; Wang X; Xie N; Li Y
    Stem Cells Int; 2018; 2018():3256524. PubMed ID: 30405719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring m6A methylation in skin Cancer: Insights into molecular mechanisms and treatment.
    Cai M; Li X; Luan X; Zhao P; Sun Q
    Cell Signal; 2024 Dec; 124():111420. PubMed ID: 39304098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine Modifications in Pulmonary Hypertension.
    Xia Y; Zhang Y; Huang J; Chen B; Jiang Y; Sun Z; Liu Y
    Pharmacology; 2023; 108(6):497-503. PubMed ID: 37742623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
    Liu Q
    Front Genet; 2021; 12():825109. PubMed ID: 35087575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Role of m6A Modification in Endocrine Cancer.
    Ji X; Wang Z; Sun W; Zhang H
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
    Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
    Front Surg; 2022; 9():819335. PubMed ID: 35155557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications.
    Wang L; Tang Y
    Biomed Pharmacother; 2023 Jul; 163():114846. PubMed ID: 37167725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis.
    Jiang X; Jin Z; Yang Y; Zheng X; Chen S; Wang S; Zhang X; Qu N
    Front Oncol; 2023; 13():1162300. PubMed ID: 37152066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression.
    Zheng QK; Ma C; Ullah I; Hu K; Ma RJ; Zhang N; Sun ZG
    Onco Targets Ther; 2021; 14():4837-4846. PubMed ID: 34556998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of DNA and RNA N6-Adenine Methylation in Regulating Stem Cell Fate.
    Wu Y; Zhou C; Yuan Q
    Curr Stem Cell Res Ther; 2018; 13(1):31-38. PubMed ID: 28637404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors.
    Yu L; Gao Y; Bao Q; Xu M; Lu J; Du W
    Heliyon; 2024 Jan; 10(2):e24414. PubMed ID: 38293446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.
    Liu S; Chen S; Tang C; Zhao Y; Cui W; Jia L; Wang L
    Front Oncol; 2022; 12():970833. PubMed ID: 36226062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine (m6A) RNA modification in cancer stem cells.
    Ma Z; Ji J
    Stem Cells; 2020 Sep; ():. PubMed ID: 32985068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies.
    Tan F; Zhao M; Xiong F; Wang Y; Zhang S; Gong Z; Li X; He Y; Shi L; Wang F; Xiang B; Zhou M; Li X; Li Y; Li G; Zeng Z; Xiong W; Guo C
    J Exp Clin Cancer Res; 2021 Apr; 40(1):146. PubMed ID: 33926508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.